Midgard Science

Nanocopoeia

New Brighton, MN, United States nanocopoeia.com From their website, Nov 2026

Work here? Claim this listing

About

Nanocopoeia is a privately held specialty research company in the Twin Cities area of Minnesota. It focuses on improving drug product performance for insoluble, low-bioavailability compounds and on generating macro-particles for oral-solid drug development.

Services

  • Drug formulation development

    Develops drug formulations using common pharmaceutical grade excipients and solvents.

  • ElectronanoSpray (ENS) atomization technology

    Uses a proprietary high-voltage unipolar atomization process based on Taylor Cone cone-jet mode to create homogeneous macro-scale drug formulation particles.

  • Out-licensing

    Offers technology through out-licensing business models.

  • Insolubility problem solving

    Works on high-value, high-barrier insolubility issues in drug products.

  • Bioavailability enhancement

    Aims to improve bio-availability performance for low-solubility drugs.

  • ElectronanoSpray technology application

    Uses proprietary atomization technology to generate homogeneous, macro-scale drug formulation particles.

  • Co-development partnering

    Collaborates with partners on shared development programs.

Instruments and platforms

  • ElectronanoSpray (ENS)

Modalities and species

Modalities
Oral-solid drug development

Industries served

  • Biotechnology
  • Pharmaceutical

Details

Founded
2001
Quality
ICH requirements (residual solvents are stated to be well below ICH requirements)
Address
639 Campus Drive New Brighton, MN 55112
Sites
  • St. Paul, United States
  • New Brighton, MN, USA
  • St. Paul, MN, USA
Phone
651.209.1184

Similar labs